Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients
Clinical trial NCT04133259 · UNKNOWN
Trial details
- NCT number
- NCT04133259
- Sponsor
- Henlix, Inc
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-31
- Primary completion
- 2022-04-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.